SYNCHRONY FINANCIAL (SYF) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "SYF",
        "SYFpA",
        "SYFpB"
      ],
      "issuer_cik": "0001601712",
      "owner_cik": "0001763554",
      "accession_number": "0001763554-26-000010",
      "form_type": "4",
      "filing_date": "2026-08-17",
      "period_of_report": "2026-08-13",
      "issuer_name": "Synchrony Financial",
      "issuer_trading_symbol": "SYF",
      "owner_name": "Casellas Alberto",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "See remarks",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-08-13",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 5456,
      "transaction_price_per_share": 80,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 50512,
      "transaction_value": 436480,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "These transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2025."
        }
      ],
      "remarks": "EVP, CEO--Health & Wellness"
    },
    {
      "tickers": [
        "SYF",
        "SYFpA",
        "SYFpB"
      ],
      "issuer_cik": "0001601712",
      "owner_cik": "0001206587",
      "accession_number": "0001206587-26-000016",
      "form_type": "4",
      "filing_date": "2026-08-04",
      "period_of_report": "2026-08-03",
      "issuer_name": "Synchrony Financial",
      "issuer_trading_symbol": "SYF",
      "owner_name": "COVIELLO ARTHUR W JR",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": false,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-08-03",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 4000,
      "transaction_price_per_share": 77.17,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 26144,
      "transaction_value": 308680,
      "not_subject_to_section_16": false,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 25, 2025."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.46 to $77.45. Information regarding the number of shares sold at each price will be provided upon request."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.